Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1990 Apr;34(4):515–518. doi: 10.1128/aac.34.4.515

Emergence of resistant fecal Escherichia coli in travelers not taking prophylactic antimicrobial agents.

B E Murray 1, J J Mathewson 1, H L DuPont 1, C D Ericsson 1, R R Reves 1
PMCID: PMC171635  PMID: 2188583

Abstract

Fecal specimens from individuals traveling to Mexico were examined before, during, and after travel for the presence of Escherichia coli resistant to ampicillin, chloramphenicol, gentamicin, kanamycin, streptomycin, sulfonamides, trimethoprim (TMP), and TMP-sulfamethoxazole (TMP-SMX). None of these individuals took prophylactic antibiotics, although 4 of 13 took short courses of an antimicrobial agent for therapy of traveler's diarrhea. With an average of 9.3 E. coli per sample, resistance to all agents tested except gentamicin was shown to increase during the time in Mexico (P less than 0.001 to P less than 0.05). For example, no TMP-resistant (Tmpr) E. coli isolates were found by this method before travel, whereas 57% of the individuals had Tmpr and Tmpr-Smxr E. coli by the final week in Mexico. This increase in resistance occurred regardless of whether an individual took a short course of antimicrobial therapy. This study shows that travel itself, even without the use of prophylactic or therapeutic antimicrobial agents, is associated with the acquisition of resistant E. coli. Travel to developing nations may rival other sources of resistant organisms.

Full text

PDF
515

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brun-Buisson C., Legrand P., Philippon A., Montravers F., Ansquer M., Duval J. Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae. Lancet. 1987 Aug 8;2(8554):302–306. doi: 10.1016/s0140-6736(87)90891-9. [DOI] [PubMed] [Google Scholar]
  2. Chambers H. F. Methicillin-resistant staphylococci. Clin Microbiol Rev. 1988 Apr;1(2):173–186. doi: 10.1128/cmr.1.2.173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. DuPont H. L., Reves R. R., Galindo E., Sullivan P. S., Wood L. V., Mendiola J. G. Treatment of travelers' diarrhea with trimethoprim/sulfamethoxazole and with trimethoprim alone. N Engl J Med. 1982 Sep 30;307(14):841–844. doi: 10.1056/NEJM198209303071401. [DOI] [PubMed] [Google Scholar]
  4. Goldstein F. W., Chumpitaz J. C., Guevara J. M., Papadopoulou B., Acar J. F., Vieu J. F. Plasmid-mediated resistance to multiple antibiotics in Salmonella typhi. J Infect Dis. 1986 Feb;153(2):261–266. doi: 10.1093/infdis/153.2.261. [DOI] [PubMed] [Google Scholar]
  5. Guerrant R. L., Wood S. J., Krongaard L., Reid R. A., Hodge R. H. Resistance among fecal flora of patients taking sulfamethoxazole-trimethoprim or trimethoprim alone. Antimicrob Agents Chemother. 1981 Jan;19(1):33–38. doi: 10.1128/aac.19.1.33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. KEAN B. H. THE DIARRHEA OF TRAVELERS TO MEXICO. SUMMARY OF FIVE-YEAR STUDY. Ann Intern Med. 1963 Nov;59:605–614. doi: 10.7326/0003-4819-59-5-605. [DOI] [PubMed] [Google Scholar]
  7. Levy S. B., Marshall B., Schluederberg S., Rowse D., Davis J. High frequency of antimicrobial resistance in human fecal flora. Antimicrob Agents Chemother. 1988 Dec;32(12):1801–1806. doi: 10.1128/aac.32.12.1801. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Murray B. E., Alvarado T., Kim K. H., Vorachit M., Jayanetra P., Levine M. M., Prenzel I., Fling M., Elwell L., McCracken G. H. Increasing resistance to trimethoprim-sulfamethoxazole among isolates of Escherichia coli in developing countries. J Infect Dis. 1985 Dec;152(6):1107–1113. doi: 10.1093/infdis/152.6.1107. [DOI] [PubMed] [Google Scholar]
  9. Murray B. E. Problems and mechanisms of antimicrobial resistance. Infect Dis Clin North Am. 1989 Sep;3(3):423–439. [PubMed] [Google Scholar]
  10. Murray B. E., Rensimer E. R., DuPont H. L. Emergence of high-level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim--sulfamethoxazole. N Engl J Med. 1982 Jan 21;306(3):130–135. doi: 10.1056/NEJM198201213060302. [DOI] [PubMed] [Google Scholar]
  11. Murray B. E. Resistance of Shigella, Salmonella, and other selected enteric pathogens to antimicrobial agents. Rev Infect Dis. 1986 May-Jun;8 (Suppl 2):S172–S181. doi: 10.1093/clinids/8.supplement_2.s172. [DOI] [PubMed] [Google Scholar]
  12. Orskov F., Sack R. B., Orskov I., Froelich J. L. Changing fecal Escherichia coli flora during travel. Eur J Clin Microbiol. 1984 Aug;3(4):306–309. doi: 10.1007/BF01977478. [DOI] [PubMed] [Google Scholar]
  13. Reves R. R., Murray B. E., Pickering L. K., Prado D., Maddock M., Bartlett A. V., 3rd Children with trimethoprim- and ampicillin-resistant fecal Escherichia coli in day care centers. J Infect Dis. 1987 Nov;156(5):758–762. doi: 10.1093/infdis/156.5.758. [DOI] [PubMed] [Google Scholar]
  14. Rowe B., Threlfall E. J. Drug resistance in gram-negative aerobic bacilli. Br Med Bull. 1984 Jan;40(1):68–76. doi: 10.1093/oxfordjournals.bmb.a071950. [DOI] [PubMed] [Google Scholar]
  15. Ryan C. A., Nickels M. K., Hargrett-Bean N. T., Potter M. E., Endo T., Mayer L., Langkop C. W., Gibson C., McDonald R. C., Kenney R. T. Massive outbreak of antimicrobial-resistant salmonellosis traced to pasteurized milk. JAMA. 1987 Dec 11;258(22):3269–3274. [PubMed] [Google Scholar]
  16. Spika J. S., Waterman S. H., Hoo G. W., St Louis M. E., Pacer R. E., James S. M., Bissett M. L., Mayer L. W., Chiu J. Y., Hall B. Chloramphenicol-resistant Salmonella newport traced through hamburger to dairy farms. A major persisting source of human salmonellosis in California. N Engl J Med. 1987 Mar 5;316(10):565–570. doi: 10.1056/NEJM198703053161001. [DOI] [PubMed] [Google Scholar]
  17. Steffen R., van der Linde F., Gyr K., Schär M. Epidemiology of diarrhea in travelers. JAMA. 1983 Mar 4;249(9):1176–1180. [PubMed] [Google Scholar]
  18. Stenderup J., Orskov I., Orskov F. Changes in serotype and resistance pattern of the intestinal Escherichia coli flora during travel. Results from a trial of mecillinam as a prophylactic against travellers' diarrhoea. Scand J Infect Dis. 1983;15(4):367–373. doi: 10.3109/inf.1983.15.issue-4.07. [DOI] [PubMed] [Google Scholar]
  19. Wells C. L., Podzorski R. P., Peterson P. K., Ramsay N. K., Simmons R. L., Rhame F. S. Incidence of trimethoprim-sulfamethoxazole-resistant enterobacteriaceae among transplant recipients. J Infect Dis. 1984 Nov;150(5):699–706. doi: 10.1093/infdis/150.5.699. [DOI] [PubMed] [Google Scholar]
  20. Wood L. V., Morgan D. R., DuPont H. L. Antimicrobial resistance of gram-negative bacteria isolated from foods in Mexico. J Infect Dis. 1983 Oct;148(4):766–766. doi: 10.1093/infdis/148.4.766. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES